RE: RE: RE: News from Oct 25Thanks for clearing that up. It does appear to be some kind of report prepared by a company however, I was interested in the line that states:
Pharmagap has entered into collaboration with MD biosciences for the development of an inhibitor of PKC isoform for use in inflammation and neurology diseases.
I haven't seen any releases by the company that talks about these two types of diseases. Is this very old news? Comments?